TrialProceedings of the National Academy of Sciences of the United States of America2020

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.

Joshi J Alumkal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.